The future of UM is AI-enabled clinical decisioning in real time
Utilization management now shapes more than status decisions. It influences documentation quality, payer challenges, denials, appeals, reimbursement and cost to collect.
In this white paper, R1 explores how healthcare organizations can move from fragmented UM workflows to a connected, intelligent decision process that identifies reimbursement risk earlier, strengthens documentation and improves the defensibility of care before payer challenges become downstream denials.
Protect reimbursement and improve financial outcomes
Why utilization management needs a new model
UM is often treated as a set of separate workflows: utilization review, physician second-level review, payer peer-to-peer review and clinical appeals.
When those functions are disconnected, denial trends may not inform front-end review, payer behavior may not be visible to teams making continued-stay recommendations and documentation gaps may be found after the best time to address them has passed.
The goal is not simply to make UM faster. It is to make UM less reactive and more connected — so teams can act while decisions can still be influenced.
What you’ll learn
Why UM should be viewed as a strategic reimbursement function, not only a review process
How to think about UM maturity across fragmented, managed and intelligent models
How the UM decision chain connects utilization review, physician review, payer escalation and clinical appeals
Which metric categories help leaders evaluate timeliness, prioritization, coverage, defensibility, financial impact and feedback loops
How AI, automation, analytics and payer intelligence can support more informed decisions without replacing clinical judgment
